Update: A buy recommendation despite the difficult environment

On June 26, 2024, Alster Research published another update on the Geratherm Group, whereby the ongoing challenges in the Healthcare Diagnostic environment and a weak first half of the year have resulted in the price target being adjusted to EUR 8.00. Alster Research continues to issue a Buy recommendation.

By obtaining MDR certification for our glass thermometer, we have laid an important foundation for the future of thermometer production. We plan to expand the portfolio with new customer-oriented and innovative products by the end of 2024.

Research Hub gives investors free access to updates of Geratherm Medical's digital coverage.

Alternatively, you can find the update as a PDF file here.